Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Keeping active can slow down memory loss in Alzheimer's patients

Keeping active can slow down the progression of memory loss in people with Alzheimer's disease, a study has shown.

25 Jan 2013

Researchers discover unique hairpin-like structure that facilitates Abeta clumping

Alzheimer's disease is the most common cause of late-life dementia. The disorder is thought to be caused by a protein known as the amyloid-beta protein, or Abeta, which clumps together in the brain, forming plaques that are thought to destroy neurons. This destruction starts early, too, and can presage clinical signs of the disease by up to 20 years.

24 Jan 2013

Hyperbaric treatment restores neurological function in damaged brains

Stroke, traumatic injury, and metabolic disorder are major causes of brain damage and permanent disabilities, including motor dysfunction, psychological disorders, memory loss, and more. Current therapy and rehab programs aim to help patients heal, but they often have limited success.

23 Jan 2013

Salk Institute to establish Helmsley Center for Genomic Medicine

The Salk Institute for Biological Studies has received a $42 million gift-the largest in the Institute's history-to establish the Helmsley Center for Genomic Medicine (HCGM), a research center dedicated to decoding the common genetic factors underlying many complex chronic human diseases.

23 Jan 2013

UCLA researchers identify abnormal tau proteins associated with sports-related concussions

Sports-related concussions and mild traumatic brain injuries have grabbed headlines in recent months, as the long-term damage they can cause becomes increasingly evident among both current and former athletes. The Centers for Disease Control and Prevention estimates that millions of these injuries occur each year.

23 Jan 2013

Cytos announces Novartis termination from NIC002 smoking cessation project

Cytos Biotechnology Ltd today announced that Novartis will discontinue the NIC002 project, which is a therapeutic vaccine candidate for the treatment of nicotine addiction.

23 Jan 2013

Amyloid clue to Parkinson’s dementia

Study findings link amyloid β burden to future cognitive decline in patients with Parkinson’s disease.

22 Jan 2013

Family members with rare gene mutation at high risk of developing schizophrenia

Johns Hopkins researchers have identified a rare gene mutation in a single family with a high rate of schizophrenia, adding to evidence that abnormal genes play a role in the development of the disease.

22 Jan 2013

Hearing loss is associated with accelerated cognitive decline and impairment in older adults

Hearing loss appears to be associated with accelerated cognitive decline and cognitive impairment in a study of older adults, according to a report published Online First by JAMA Internal Medicine, a JAMA Network publication.

22 Jan 2013

Biophysical Society Annual Meeting to highlight innovations in medicine, physics, and more

Honeybee silk-inspired materials; a deconstruction of the Ebola virus; how microbes evolve resistance to antibiotics; and a possible connection between Alzheimer's disease and type II diabetes are just some of the intriguing topics that will be presented at the 57th Annual Meeting of the Biophysical Society (BPS).

22 Jan 2013

New study: Loneliness can harm overall health

New research links loneliness to a number of dysfunctional immune responses, suggesting that being lonely has the potential to harm overall health.

20 Jan 2013

New model of tau pathology spread

Brain diseases associated with the misformed protein tau, including Alzheimer's disease and frontotemporal lobar degeneration with tau pathologies, are characterized by neurofibrillary tangles (NFTs) comprised of pathological tau filaments.

19 Jan 2013

RSAS honors Feinstein Institute scientist with Crafoord Prize for genetic research on arthritis

The Royal Swedish Academy of Sciences announced today that Peter K. Gregersen , MD, a scientist at The Feinstein Institute for Medical Research, will receive the prestigious Crafoord Prize for his genetic research in the area rheumatoid arthritis.

18 Jan 2013

Children's Oakland recruits patients for deferiprone clinical trial to treat PKAN

A groundbreaking, international clinical trial of an iron chelation drug, deferiprone, to treat the rare and devastating neurodegenerative disease, pantothenate kinase-associated neurodegeneration (PKAN), began last month at the trial's only North American site, Children's Hospital & Research Center Oakland.

17 Jan 2013

Athletes with concussions in early adulthood may be at increased risk of depression as they age

National Football League (NFL) players may be at increased risk of depression as they age due to brain damage resulting from concussions, according to two studies released today that will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013.

17 Jan 2013

MPL vaccine can stimulate brain's natural defense mechanisms in people with AD

A team of researchers from Universit- Laval, CHU de Qu-bec, and pharmaceutical firm GlaxoSmithKline (GSK) has discovered a way to stimulate the brain's natural defense mechanisms in people with Alzheimer's disease.

17 Jan 2013

Women who have migraine with aura more likely to develop major cardiovascular events

Women who have migraines with aura, which are often visual disturbances such as flashing lights, may be more likely to have problems with their heart and blood vessels, and those on newer contraceptives may be at higher risk for blood clots, according to two studies released today that will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013.

17 Jan 2013

State roundup: Maine hospitals fighting for timely Medicaid payments

New York police plan to distribute "bait bottles" of fake pain-killers equipped with invisible GPS devices in a drive to combat the scourge of pharmacy robberies by addicts and sellers looking for oxycodone tablets, which can fetch more than $80 per pill on the street.

17 Jan 2013

University of Hertfordshire to lead two new Govt-funded projects into dementia research

Researchers at the University of Hertfordshire are leading two of the twenty-one new Government-funded projects into dementia research - to boost dementia diagnosis rates and trial ground-breaking treatments, as well as helping people with dementia live well with the condition today.

17 Jan 2013

Stroke survivors with depression more likely to die

People who are depressed after a stroke may have a tripled risk of dying early and four times the risk of death from stroke than people who have not experienced a stroke or depression, according to a study that will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013.

16 Jan 2013

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Keeping active can slow down memory loss in Alzheimer's patients

Researchers discover unique hairpin-like structure that facilitates Abeta clumping

Hyperbaric treatment restores neurological function in damaged brains

Salk Institute to establish Helmsley Center for Genomic Medicine

UCLA researchers identify abnormal tau proteins associated with sports-related concussions

Cytos announces Novartis termination from NIC002 smoking cessation project

Amyloid clue to Parkinson’s dementia

Family members with rare gene mutation at high risk of developing schizophrenia

Hearing loss is associated with accelerated cognitive decline and impairment in older adults

Biophysical Society Annual Meeting to highlight innovations in medicine, physics, and more

New study: Loneliness can harm overall health

New model of tau pathology spread

RSAS honors Feinstein Institute scientist with Crafoord Prize for genetic research on arthritis

Children's Oakland recruits patients for deferiprone clinical trial to treat PKAN

Athletes with concussions in early adulthood may be at increased risk of depression as they age

MPL vaccine can stimulate brain's natural defense mechanisms in people with AD

Women who have migraine with aura more likely to develop major cardiovascular events

State roundup: Maine hospitals fighting for timely Medicaid payments

University of Hertfordshire to lead two new Govt-funded projects into dementia research

Stroke survivors with depression more likely to die

Innovation in neuroscience drug discovery - eBook eBook

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Innovation in neuroscience drug discovery - eBook eBook

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

Newsletters you may be interested in